Organization Overview
Alternative names
alemtuzumab (campath) (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (2 trials)
amphotericin b (fungizone) (1 trial)
arsenic trioxide (trisenox) (1 trial)
autologous bone marrow (1 trial)
azacitidine (vidaza) (1 trial)
azithromycin (zithromax) (1 trial)
capecitabine (xeloda) (4 trials)
cladribine (leustatin) (1 trial)
clofarabine (clolar) (1 trial)
clonidine (catapres) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (4 trials)
daunorubicin (cerubidine) (4 trials)
dexmedetomidine (precedex) (1 trial)
etoposide (vepesid) (2 trials)
gemtuzumab ozogamicin (mylotarg) (3 trials)
hydroxyurea (hydrea) (1 trial)
ibandronate (boniva) (1 trial)
idarubicin (idamycin) (2 trials)
immune globulin (human) (2 trials)
methylprednisolone (medrol) (1 trial)
mitoxantrone (novantrone) (2 trials)
acetylsalicylic acid (aspirin) (2 trials)
bifidobacterium animalis (1 trial)
blinatumomab (blincyto) (1 trial)
cyanocobalamin (berocca) (1 trial)
enoxaparin (lovenox) (1 trial)
fulvestrant (faslodex) (1 trial)
gemcitabine (gemzar) (4 trials)
irinotecan (Camptosar) (1 trial)
nitric oxide (inomax) (1 trial)
Acute Lung Injury (Phase 2)
Adrenal Insufficiency (Phase 4)
Agammaglobulinemia (Phase 3)
Anus Neoplasms (Phase 1)
Arachnodactyly (Phase 4)
Arthritis (Phase 2)
Arthritis, Rheumatoid (Phase 2)
Breast Neoplasms (Phase 3)
Bronchopulmonary Dysplasia (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Carcinosarcoma (Phase 2)
Colitis (Phase 3)
Colitis, Ulcerative (Phase 3)
Colorectal Neoplasms (Phase 2)
Common Cold (Phase 3)
Common Variable Immunodeficiency (Phase 3)
Communicable Diseases (Phase 3)
Critical Illness (Phase 3)
Dementia (Phase 3)
Depression (Phase 4)
Depressive Disorder (Phase 4)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Embolism (Phase 2)
Endometrial Neoplasms (Phase 2)
Esophageal and Gastric Varices (Phase 4)
Esophageal Neoplasms (Phase 3)
Eye Diseases (Phase 4)
Fatigue (Phase 2)
Graves Disease (Phase 2)
Graves Ophthalmopathy (Phase 4)
Hemophilia A (Phase 4)
Hypercalcemia (Phase 3)
Hypopituitarism (Phase 4)
Immunologic Deficiency Syndromes (Phase 3)
Infections (Phase 3)
Invasive Fungal Infections (Phase 3)
Kidney Neoplasms (Phase 2)
Leg Ulcer (Phase 2)
Leukemia (Phase 3)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Liver Cirrhosis (Phase 4)
Lung Injury (Phase 2)
Lung Neoplasms (Phase 2)
Lymphangioleiomyomatosis (Phase 2)
Marfan Syndrome (Phase 4)
Mesothelioma (Phase 2)
Mixed Tumor, Mullerian (Phase 2)
Multiple Myeloma (Phase 2)
Mycoses (Phase 3)
Myelitis (Phase 3)
Myelitis, Transverse (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Plasma Cell (Phase 2)
Neuromyelitis Optica (Phase 3)
Neutropenia (Phase 3)
Oropharyngeal Neoplasms (Phase 3)
Pancreatic Neoplasms (Phase 2)
Parkinson Disease (Phase 4)
Preleukemia (Phase 3)
Pulmonary Embolism (Phase 2)
Purpura, Thrombocytopenic, Idiopathic (Phase 3)
Rectal Neoplasms (Phase 2)
Respiratory Distress Syndrome (Phase 2)
Respiratory Distress Syndrome, Newborn (Phase 2)
Schizophrenia (Phase 4)
Sclerosis (Phase 2)
Skin Ulcer (Phase 2)
Staphylococcal Infections (Phase 2)
Syndrome (Phase 4)
Thrombocytopenia (Phase 3)
Thromboembolism (Phase 2)
Thrombosis (Phase 2)
Tuberous Sclerosis (Phase 2)
Ulcer (Phase 3)
Ureteral Neoplasms (Phase 2)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Varicose Ulcer (Phase 2)
Varicose Veins (Phase 4)
Venous Thromboembolism (Phase 2)
Venous Thrombosis (Phase 2)